Authors:
BRYCE TJ
DEWHIRST MW
FLOYD CE
HARS V
BRIZEL DM
Citation: Tj. Bryce et al., ARTIFICIAL NEURAL-NETWORK MODEL OF SURVIVAL IN PATIENTS TREATED WITH IRRADIATION WITH AND WITHOUT CONCURRENT CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE HEAD AND NECK, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 339-345
Authors:
BRIZEL DM
ALBERS ME
FISHER SR
SCHER RL
RICHTSMEIER WJ
HARS V
GEORGE SL
HUANG AT
PROSNITZ LR
Citation: Dm. Brizel et al., HYPERFRACTIONATED IRRADIATION WITH OR WITHOUT CONCURRENT CHEMOTHERAPYFOR LOCALLY ADVANCED HEAD AND NECK-CANCER, The New England journal of medicine, 338(25), 1998, pp. 1798-1804
Authors:
BRYCE TJ
DEWHIRST MW
FLOYD CE
HARS V
BRIZEL DM
Citation: Tj. Bryce et al., AN ARTIFICIAL NEURAL-NETWORK PREDICTIVE MODEL OF SURVIVAL IN PATIENTSTREATED FOR ADVANCED-CARCINOMA OF THE HEAD AND NECK, Radiology, 205, 1997, pp. 1419-1419
Citation: Lj. Coetzee et al., PROLIFERATIVE INDEX DETERMINATION IN PROSTATIC-CARCINOMA TISSUE - IS THERE ANY ADDITIONAL PROGNOSTIC VALUE GREATER-THAN THAT OF GLEASON SCORE, PLOIDY AND PATHOLOGICAL STAGE, The Journal of urology, 157(1), 1997, pp. 214-218
Citation: M. Gautier et al., PROGNOSTIC FACTORS IN SURVIVAL FOR PATIENTS WITH MULTIPLE-MYELOMA FROM A SINGLE INSTITUTION OVER 30 YEARS, Blood, 90(10), 1997, pp. 4089-4089
Authors:
DEMARKWAHNEFRIED W
HARS V
CONAWAY MR
HAVLIN K
RIMER BK
MCELVEEN G
WINER EP
Citation: W. Demarkwahnefried et al., REDUCED RATES OF METABOLISM AND DECREASED PHYSICAL-ACTIVITY IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY, The American journal of clinical nutrition, 65(5), 1997, pp. 1495-1501
Citation: Lj. Coetzee et al., POSTOPERATIVE PROSTATE-SPECIFIC ANTIGEN AS A PROGNOSTIC INDICATOR IN PATIENTS WITH MARGIN-POSITIVE PROSTATE-CANCER, UNDERGOING ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY, Urology, 47(2), 1996, pp. 232-235
Authors:
HUSSEIN AM
ROSS M
VREDENBURGH J
MEISENBERG B
HARS V
GILBERT C
PETROS WP
CONIGLIO D
KURTZBERG J
RUBIN P
PETERS WP
Citation: Am. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, European journal of haematology, 54(5), 1995, pp. 281-287